Actionable pathways: interactive discovery of therapeutic targets using signaling pathway models.

Nucleic Acids Res

Computational Genomics Department, Centro de Investigación Príncipe Felipe (CIPF), Valencia, 46012, Spain Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, 46012, Spain Functional Genomics Node, (INB, PRB2, ISCIII) at CIPF, Valencia 46012, Spain

Published: July 2016

The discovery of actionable targets is crucial for targeted therapies and is also a constituent part of the drug discovery process. The success of an intervention over a target depends critically on its contribution, within the complex network of gene interactions, to the cellular processes responsible for disease progression or therapeutic response. Here we present PathAct, a web server that predicts the effect that interventions over genes (inhibitions or activations that simulate knock-outs, drug treatments or over-expressions) can have over signal transmission within signaling pathways and, ultimately, over the cell functionalities triggered by them. PathAct implements an advanced graphical interface that provides a unique interactive working environment in which the suitability of potentially actionable genes, that could eventually become drug targets for personalized or individualized therapies, can be easily tested. The PathAct tool can be found at: http://pathact.babelomics.org.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987920PMC
http://dx.doi.org/10.1093/nar/gkw369DOI Listing

Publication Analysis

Top Keywords

actionable pathways
4
pathways interactive
4
interactive discovery
4
discovery therapeutic
4
therapeutic targets
4
targets signaling
4
signaling pathway
4
pathway models
4
models discovery
4
discovery actionable
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!